Entity type
Company
Filer Snapshot
abrdn Life Sciences Investors
CIK 0000884121. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Total filings
68
Latest filing
20 Jul 2026
Industry
n/a
Filing-backed research brief
Start with the SEC data that changes for this CIK
Latest signal: SEC filing timeline only. Each card links back to the PortfolioSavvy page where the filing evidence is closest.
Latest 13F portfolio
—
No parsed 13F portfolio row yet.
Browse latest 13FLargest parsed holding
—
Populates from the latest parsed 13F information table.
Open holding13D/G large stake
—
No recent parsed 13D/G stake row for this CIK.
Browse 13D/GInsider / owner context
—
No parsed Forms 3/4/5 owner position for this CIK.
Browse insider filingsSave this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Source: SEC Forms 3/4/5
View source filing
4 filed on 20 Jul 2026 for CIK 0000884121.
- Listed symbols
- HQL on NYSE
- Business address
- 1900 Market Street, Suite 200, Philadelphia, PA, 19103
- Incorporated in
- MA
- Fiscal year end
- 30 September
- Former names on EDGAR
- TEKLA LIFE SCIENCES INVESTORS (to 05 Oct 2023), H&Q LIFE SCIENCES INVESTORS (to 18 Sep 2014)
At a glance
Names, identifiers, and filing context for this profile.
1 identity field
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 3 profile fields available
Filer intelligence
What SEC filings say about abrdn Life Sciences Investors
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
SEC source mix
Counts show available parsed rows, not one combined ownership total.
13F portfolio
No rows yet
Quarterly institutional portfolio holdings.
13D/G stakes
No rows yet
Beneficial ownership and large-stake disclosures.
Forms 3/4/5
No rows yet
Officer, director, and 10% owner holdings or transactions.
No parsed ownership summary yet
We still show the SEC filing timeline below. The intelligence summary will populate when parsed 13F, 13D/G, or Forms 3/4/5 data exists for this CIK.
SEC filing record
CIK 0000884121 filing coverage
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
SEC filings
68
First seen
22 Mar 2024
Latest filing
20 Jul 2026
Entity
Company
Observed form types
3
4
Latest Filings
Showing the latest 12 of 68 SEC filings for abrdn Life Sciences Investors.
4
4 filing
- Filing date
- 20 Jul 2026
- Reporting date
- 16 Jul 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
3
3 filing
- Filing date
- 11 Jun 2026
- Reporting date
- 09 Jun 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
3
3 filing
- Filing date
- 19 Dec 2025
- Reporting date
- 09 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 18 Dec 2025
- Reporting date
- 16 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 23 Sep 2025
- Reporting date
- 19 Sep 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 19 Sep 2025
- Reporting date
- 17 Sep 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 17 Sep 2025
- Reporting date
- 15 Sep 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 15 Sep 2025
- Reporting date
- 11 Sep 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 04 Sep 2025
- Reporting date
- 02 Sep 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 02 Sep 2025
- Reporting date
- 29 Aug 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 27 Aug 2025
- Reporting date
- 26 Aug 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 25 Aug 2025
- Reporting date
- 21 Aug 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing